Experts in translational oncology and targeted protein degradation join Dr Simon Cook, Dr Lorenz Mayr and Dr Catherine Beech to provide scientific and strategic oversight
Cambridge, UK, 17 July 2023: PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, today announced Professor Peter Parker and Dr Jason Imbriglio as members of its Scientific Advisory Board (SAB). Professor Parker and Dr Imbriglio will join existing SAB members, Dr Simon Cook (Institute Director, Babraham Institute and PhoreMost SAB Chair), Dr Lorenz Mayr (CEO, Vector Biopharma…
Anglia Ruskin University (ARU) and Writtle University College are delighted to announce a proposal to merge the two institutions.
The proposed merger will secure a long-term, sustainable future for Writtle, and unlock significant opportunities for growth and development by bringing together the two institutions’ strengths across education and research.
Now in its 130th year and located on the outskirts of Chelmsford, Writtle University College is one of the UK’s leading institutions for land-based studies.
It offers postgraduate, undergraduate, further education and short courses in the areas…
Leading science and innovation campus, Discovery Park, in Sandwich, Kent has launched a new business support programme and competition, ‘Discovery Spark’. The programme will lay healthy foundations for future company success and equip early stage life science businesses with the skills needed when pitching to investors.
The free and hybrid programme running over the course of eight weeks, aims to ignite potential from the best of Discovery Park’s facilities, people and networks. Delivered in four in-person sessions, plus mentoring, networking and group learning, the sessions will cover teams…
Click here to view the July 2023 edition of The Meeting Place!
In this short video, Mike Davies, CEO of Carocell Bio, shares insights into their fascinating technology and how it could improve the lives of patients with anti-inflammatory peptides applied topically to the skin. This approach has great potential to treat and prevent the recurrence of eczema and has potential anti-ageing properties.
Watch the video
Interested in learning more? Visit their website: https://carocellbio.com/
Scaling up – how space is the key ingredient to superpower status
Much has been made of the government's plan to cement the UK as a Scientific Superpower, but beyond a title, what does this really entail? In short, it means opening the cheque book and making the UK more attractive to international talent and investment. This will enable the UK to build up its infrastructure and skill set – both of which are crucial for growing the industry. The physical, real estate, and various scientific infrastructure that sits alongside it, coupled with the workforce that occupies these buildings and…
Domainex significantly expands its footprint, leasing the first of three new laboratory buildings at Unity Campus
Cambridge, 10th July 2023: Leading regional property investor and developer Howard Group is delighted to confirm the letting of Building A2 to Domainex, a leading integrated medicines research services partner and recent recipient of a King’s Award for Enterprise. A2 is one of three new laboratory buildings currently under construction at Unity Campus, all of which are due for completion later this year.
The three-storey Building A2 of over 24,000 sq ft…
Edinburgh and Cambridge, UK, 7 July 2023 - Macomics Ltd, a leader in macrophage drug discovery, is delighted to announce that it was voted as the winner of the 2023 BioNewsRound Award for the news of its worldwide drug discovery collaboration agreement with Ono Pharmaceutical Co., Ltd. to develop new immuno-oncology antibody drugs against a novel macrophage target of interest in cancer, announced in March.
Sue Charles, consultant to Macomics collecting the award from Tony Jones, CEO One Nucleus, on behalf of CEO Steve Myatt
The Award, organised by leading trade association One Nucleus, seeks…
Dr Stevens promoted from Director of Drug Discovery, and Dr Kirby promoted from Director of Operations
Cambridge, UK, 06 July 2023: Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the appointments of Dr Robert Kirby to Chief Operating Officer and Dr Edward Stevens to Chief Scientific Officer. Both appointments represent promotions from within the company.
After relocating to larger Company headquarters in 2021and a period of rapid recruitment in 2022, Metrion’s customer base and scale of operations has continued…
Life Sciences industry entrepreneur joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 06 July 2023 - One Nucleus, the Cambridge based not-for-profit membership organisation for life science businesses, is delighted to announce the appointment of Prashant Shah, the serial deep tech entrepreneur and investor as a Non-Executive Director. Prashant is co-CEO and co-Founder of o2h, leading on the development of the Mill SciTech Park, supporting the creation of innovative life science and tech-bio companies.
Prashant’s impressive CV includes a…